Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parotid Neoplasms | 2 | 2007 | 49 | 0.540 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2007 | 10 | 0.300 |
Why?
|
| Paresthesia | 1 | 2006 | 8 | 0.280 |
Why?
|
| Dysgeusia | 1 | 2006 | 4 | 0.280 |
Why?
|
| Tongue | 1 | 2006 | 20 | 0.280 |
Why?
|
| Microsurgery | 1 | 2006 | 46 | 0.270 |
Why?
|
| Laryngoscopy | 1 | 2006 | 61 | 0.270 |
Why?
|
| Sarcoma, Kaposi | 1 | 2005 | 24 | 0.260 |
Why?
|
| HIV Seropositivity | 1 | 2005 | 65 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2008 | 444 | 0.140 |
Why?
|
| Neck Dissection | 2 | 2005 | 55 | 0.120 |
Why?
|
| Head and Neck Neoplasms | 3 | 2008 | 561 | 0.110 |
Why?
|
| Thyroid Neoplasms | 1 | 2012 | 68 | 0.100 |
Why?
|
| Lymphatic Metastasis | 2 | 2012 | 274 | 0.090 |
Why?
|
| Radiology, Interventional | 1 | 2008 | 21 | 0.080 |
Why?
|
| Intraoperative Care | 1 | 2008 | 91 | 0.080 |
Why?
|
| Mediastinum | 1 | 2007 | 39 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 2008 | 120 | 0.070 |
Why?
|
| Wound Healing | 2 | 2008 | 260 | 0.070 |
Why?
|
| Lingual Nerve Injuries | 1 | 2006 | 5 | 0.070 |
Why?
|
| Laryngeal Diseases | 1 | 2006 | 22 | 0.070 |
Why?
|
| Adenolymphoma | 1 | 2005 | 1 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 572 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 3256 | 0.070 |
Why?
|
| Tongue Neoplasms | 1 | 2005 | 28 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 191 | 0.060 |
Why?
|
| Postoperative Complications | 3 | 2008 | 1615 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2008 | 624 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 235 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 375 | 0.060 |
Why?
|
| Middle Aged | 5 | 2012 | 21119 | 0.060 |
Why?
|
| Adult | 4 | 2012 | 21375 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 682 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 1139 | 0.050 |
Why?
|
| Incidence | 1 | 2006 | 1582 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2002 | 141 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2004 | 597 | 0.050 |
Why?
|
| Humans | 9 | 2012 | 68525 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2008 | 7264 | 0.040 |
Why?
|
| Female | 4 | 2012 | 38015 | 0.040 |
Why?
|
| Male | 4 | 2012 | 37281 | 0.040 |
Why?
|
| Aged | 3 | 2012 | 14842 | 0.040 |
Why?
|
| Adolescent | 2 | 2008 | 8903 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2012 | 799 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 4843 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 2222 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2012 | 31 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 2012 | 35 | 0.030 |
Why?
|
| SEER Program | 1 | 2012 | 150 | 0.030 |
Why?
|
| Carcinoma | 1 | 2012 | 215 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 791 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2008 | 7028 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2008 | 20 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2008 | 125 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1860 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 467 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2008 | 652 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2005 | 33 | 0.020 |
Why?
|
| Glossectomy | 1 | 2005 | 9 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2004 | 14 | 0.020 |
Why?
|
| Papilloma | 1 | 2004 | 8 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2004 | 22 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 129 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 475 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 125 | 0.020 |
Why?
|
| Carcinogens | 1 | 2004 | 86 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 122 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 138 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2004 | 45 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2004 | 238 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 146 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 183 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2005 | 311 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 231 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 951 | 0.010 |
Why?
|
| Neck | 1 | 2002 | 62 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 451 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 258 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2004 | 1173 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 1070 | 0.010 |
Why?
|
| Quality of Life | 1 | 2005 | 1515 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 8472 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 20877 | 0.000 |
Why?
|